For example, after Ozempic, Novo Nordisk released semaglutide in different formulation strengths specifically targeted at weight loss (as Wegovy) and then subsequently as Rybelsus, an oral formulation [18, 87, 88]
This version is commonly known by the brand names Ozempic and Wegovy
10.2337/db15-0443 32 IshikawaM.NakazawaT.KunikataH.SatoK.YoshitomiT.KrishnanK.et al (2022)
Despite no FDA approval or official assessment of safety and efficacy, various US providers have begun prescribing and promoting the use of retatrutide for weight loss, according to a 1 The excitement surrounding emerging obesity therapies is understandable, especially when early clinical trial results appear promising, Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, professor of pharmacy practice at the Massachusetts College of Pharmacy and Health Sciences and co-host of Drug Topics Wicked Good Cardiometabolic Chat podcast, said
Luo J, et al